Figure 2. Middle cerebral artery (MCA) endothelium-dependent and -independent dilation.
A, MCA endothelium-dependent dilatation to ACh in the absence or presence of l-NAME measured by pressure myography in Eln+/+ and Eln+/– mice (n = 16 per group, significance marks denote a time by group interaction or main effect for group from repeated-measures ANOVAs). B, maximal MCA dilatation to ACh in the absence and presence of l-NAME alone and in combination with the cyclooxygenase inhibitor indomethacin (INDO) in Eln+/+ and Eln+/– mice (n = 6–7 per group). C, MCA endothelium-independent dilatation to sodium nitroprusside in Eln+/+ and Eln+/– mice (n = 10–12 per group). *P < 0.05 vs. Eln+/+ ACh alone, †P < 0.05 vs. Eln+/– ACh alone, ‡P < 0.05 vs. Eln+/+ ACh with l-NAME, §P < 0.05 vs. Eln+/– ACh with l-NAME. Values are mean ± SEM.